Abiopharma

🔍 Szwarcberg Javier B. (Executive)

Company: SPRUCE BIOSCIENCES, INC. (SPRB)

Report Date: 2025-12-31

Detailed Transactions and Holdings:

• Acquired 4,690 shares of Common Stock at $4.5305 per share (Direct)
  Date: 2025-12-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 19,004.00 | transaction_form_type: 5 | Footnotes: F1

Footnotes:

• F1: Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The Reporting Person acquired the maximum shares allowable pursuant to Section 423 of the Internal Revenue Code.